Dockendorff Charles J
Director at BSX; Director at HOLX; Director at HAE, and 2 more
- Sold, on record
- $44M
- Dollars the filings state
- Form 4 sales
- 18
- Latest May 7, 2024
- Form 144 notices
- 5
- Proposed sales
- Companies
- 5
- Filed as an executive or holder
Companies
- BSXBOSTON SCIENTIFIC CORPDirector
- HOLXHOLOGIC INCDirector
- HAEHAEMONETICS CORPDirector
- KEYSKeysight Technologies, Inc.Director
- Covidien Ltd.EVP & Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Covidien Ltd.620,404 shares
- HAE22,395 shares
- BSX21,025 shares
- HOLX17,482 shares
- KEYS3,257 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice HAENoticeSep 5, 2023 2023
Filed to sell 10,215 shares ($915k)
Dockendorff Charles J, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale HAERoutineSep 5, 2023 same day
Sold 10,215 shares at $87.68 ($896k)
Dockendorff Charles J, Director
10b5-1 planSold 82.1% of holdings ($1.1M position)2,226 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice HOLXNoticeJan 2, 2024 +119 days
Filed to sell 16,017 shares ($1.2M)
Dockendorff Charles J, Director
10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale HOLXRoutineJan 2, 2024 same day
Sold 16,017 shares at $72.00 ($1.2M)
Dockendorff Charles J, Director
10b5-1 planSold 91.6% of holdings ($1.3M position)1,465 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice HOLXNoticeMar 8, 2024 +66 days
Filed to sell 1,465 shares ($112k)
Dockendorff Charles J, Director
10b5-1 planFiling
- 6 Form 4 sale HOLXRoutineMar 8, 2024 same day
Sold 1,465 shares at $76.21 ($112k)
Dockendorff Charles J, Director
10b5-1 planSold 48.2% of holdings ($231k position)1,572 shares leftFollows a Form 144Filing
- 7 Form 144 notice BSXNoticeMay 7, 2024 +60 days
Filed to sell 3,946 shares ($287k)
Dockendorff Charles J, Director
10b5-1 planFiling
- 8 Form 4 sale BSXRoutineMay 7, 2024 same day
Sold 3,946 shares at $72.70 ($287k)
Dockendorff Charles J, Director
10b5-1 planSold 100% of holdings ($287k position)0 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | May 8, 2024 | BSX | Director | Form 4 sale | 3,946 | $287k | 100.0% | Routine | SEC |
| May 7, 2024 | May 7, 2024 | BSX | Director | Form 144 notice | 3,946 | $287k | Notice | SEC | |
| Mar 8, 2024 | Mar 11, 2024 | HOLX | Director | Form 4 sale | 1,465 | $112k | 48.2% | Routine | SEC |
| Mar 8, 2024 | Mar 8, 2024 | HOLX | Director | Form 144 notice | 1,465 | $112k | Notice | SEC | |
| Jan 2, 2024 | Jan 4, 2024 | HOLX | Director | Form 4 sale | 16,017 | $1.2M | 91.6% | Routine | SEC |
| Jan 2, 2024 | Jan 2, 2024 | HOLX | Director | Form 144 notice | 16,017 | $1.2M | Notice | SEC | |
| Sep 5, 2023 | Sep 7, 2023 | HAE | Director | Form 4 sale | 10,215 | $896k | 82.1% | Routine | SEC |
| Sep 5, 2023 | Sep 5, 2023 | HAE | Director | Form 144 notice | 10,215 | $915k | Notice | SEC | |
| Aug 18, 2023 | Aug 18, 2023 | BSX | Director | Form 144 notice | 17,079 | $867k | Notice | SEC | |
| Aug 18, 2023 | Aug 18, 2023 | BSX | Director | Form 4 sale | 17,079 | $867k | 81.2% | Routine | SEC |
| Dec 13, 2022 | Dec 14, 2022 | KEYS | Director | Form 4 sale | 3,257 | $603k | 5.8% | Plan not stated | SEC |
| Feb 4, 2021 | Feb 5, 2021 | HAE | Director | Form 4 sale | 12,180 | $1.6M | 47.0% | Unusual | SEC |
| Mar 28, 2014 | Mar 28, 2014 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 90,730 | $6.6M | 44.7% | Unusual | SEC |
| Jan 10, 2014 | Jan 10, 2014 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 90,000 | $6.3M | 44.5% | Unusual | SEC |
| Nov 15, 2013 | Nov 15, 2013 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 39,397 | $2.6M | 26.1% | Unusual | SEC |
| Aug 8, 2013 | Aug 8, 2013 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 95,188 | $6M | 40.9% | Unusual | SEC |
| Feb 11, 2013 | Feb 12, 2013 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 32,457 | $2.1M | 19.3% | Plan not stated | SEC |
| Nov 23, 2012 | Nov 26, 2012 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 134,129 | $7.6M | 50.1% | Unusual | SEC |
| May 3, 2011 | May 4, 2011 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 78,399 | $4.4M | 42.2% | Unusual | SEC |
| Jan 20, 2010 | Jan 22, 2010 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 19,599 | $1M | 16.8% | Plan not stated | SEC |
| Nov 17, 2009 | Nov 18, 2009 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 12,800 | $589k | 12.6% | Plan not stated | SEC |
| Nov 10, 2009 | Nov 12, 2009 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 6,800 | $306k | 7.1% | Plan not stated | SEC |
| May 13, 2008 | May 15, 2008 | Covidien Ltd. | EVP & Chief Financial Officer | Form 4 sale | 20,905 | $1M | 19.7% | Plan not stated | SEC |